VA-CMHC-Yale Schizophrenia Research Program

Mission

To study the pathophysiology of schizophrenia and to develop better treatments for it.

Research Portfolio

  • Laboratory Studies¬† of Psychotomimetic Drugs in Healthy Humans
  • Development of stand-alone and add-on treatments for positive, negative and cognitive symptoms of schizophrenia¬†
  • Brain imaging (PET, MRI, EEG)
  • Cognitive Remediation
  • Genetics¬†

Who is eligible?

  • Individuals diagnosed with Schizophrenia or other psychotic disorders.
  • Healthy Controls

Leadership

Yale Faculty

Deepak Cyril Dsouza, MBBS, MD

Professor of Psychiatry

Director Schizophrenia Neuropharmacology Research Group at Yale (SNRGY)

Director, Neurobiological Studies Unit, VACHS

Director, VA-CMHC Schizophrenia Research Clinic

View Full Profile

Mohini Ranganathan, MBBS

Assistant Professor of Psychiatry

View Full Profile

Patrick D. Skosnik, PhD

Assistant Professor of Psychiatry

View Full Profile

Zoran Zimolo, MD, PhD

Assistant Professor of Psychiatry

View Full Profile

Contact Us

For more information about the clinic and our research programs, please call Kimberlee Forselius at 203-974-7540.

Locations